{"id":12761,"date":"2016-01-28T10:00:16","date_gmt":"2016-01-28T18:00:16","guid":{"rendered":"https:\/\/sop.washington.edu\/?p=12761"},"modified":"2023-07-26T13:15:18","modified_gmt":"2023-07-26T20:15:18","slug":"uwsop-and-icer-form-collaboration","status":"publish","type":"post","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/","title":{"rendered":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications"},"content":{"rendered":"<p>The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage UWSOP\u2019s expertise in economic modeling of pharmaceutical interventions to support ICER\u2019s growing body of work in new drug assessments. UWSOP\u2019s Pharmaceutical Outcomes Research and Policy Program (PORPP) will provide health economic consulting support to ICER for use in ICER\u2019s reports for its drug assessment program. PORPP is internationally renowned for its excellence in pharmacoeconomics and cost-effectiveness modeling, and ICER is a leader in producing reports that address the clinical effectiveness, cost-effectiveness, and potential budgetary impact of high-profile interventions. As part of the agreement, UWSOP\u2019s researchers will develop cost-effectiveness models for several drugs that are soon-to-be or recently approved by the FDA, leveraging evidence synthesis work performed by ICER and publicly-available data.<\/p>\n<p>\u201cThis partnership allows us to broaden the impact of our technical and scientific expertise within the UWSOP to increase information about the clinical and economic impact of new medications in the U.S. health system,\u201d said Anirban Basu, Ph.D., Professor and Director of PORPP.<\/p>\n<p>\u201cWhen producing our reports, we are always striving to utilize the most up-to-date methodology possible to produce actionable information that can provide guidance regarding the comparative effectiveness and value of new prescription drugs,\u201d Daniel A. Ollendorf, PhD, ICER\u2019s Chief Scientific Officer noted. \u201cUWSOP\u2019s esteemed faculty has a wealth of experience across multiple clinical areas, and we are thrilled to cement this partnership.\u201d<\/p>\n<p>ICER\u2019s reports include a full analysis of a drug\u2019s comparative effectiveness, cost-effectiveness, and potential budget impact. ICER uses transparent methods to calculate for each new drug a value-based price benchmark anchored to the real benefits the drug brings to patients. UWSOP will employ robust and commonly used health economics methods to estimate the comparative impact of select new medications in terms of their incremental costs per outcomes achieved. These findings will be incorporated into ICER\u2019s larger reports. UWSOP will be providing expertise on the cost-effectiveness analyses, while ICER will ultimately be responsible for calculating the value-based price benchmark.<\/p>\n<p>The initial project will focus on treatments for &#8220;relapsed&#8221; or \u201crefractory\u201d multiple myeloma (i.e., disease that is unresponsive to initial therapy or progressing after treatment). The specific scope for the report, including a complete list of the drugs to be reviewed, will be announced in a draft document scheduled to be released on February 5, 2016.<\/p>\n<p style=\"text-align: center;\">***<\/p>\n<p><strong>About UWSOP<\/strong><\/p>\n<p>The <a href=\"https:\/\/sop.washington.edu\/\">University of Washington School of Pharmacy<\/a> (UWSOP) is a global leader in pharmacy education, research and service, committed to providing a transformative learning experience in a collaborative and diverse environment focused on improving the health and well-being of the communities we serve. UWSOP is comprised of three departments: Medicinal Chemistry, Pharmaceutics, and Pharmacy, offering Ph.D., M.S., and PharmD degrees, post docs and certificate programs. The Department of Pharmacy leads in pharmacy education, research, professional and outreach initiatives, including the Pharmaceutical Outcomes Research &amp; Policy Program (PORPP), which conducts research in pharmaceutical economics, drug safe and pharmaceutical policy.\u00a0Click \u00a0for\u00a0more information about our\u00a0<a href=\"https:\/\/sop.washington.edu\/phd-ms\/\">Graduate Programs in Pharmaceutical Outcomes Research and Policy and Biomedical Regulatory Affairs.<\/a><\/p>\n<p><strong>About ICER<\/strong><\/p>\n<p>The Institute for Clinical and Economic Review (ICER) is an independent non-profit research institute\u00a0that produces reports analyzing the evidence on the effectiveness and value of drugs and other\u00a0medical services. ICER\u2019s reports\u00a0include evidence-based calculations of\u00a0prices for new drugs\u00a0that\u00a0accurately\u00a0reflect the degree of improvement\u00a0expected\u00a0in long-term\u00a0patient outcomes, while also\u00a0highlighting price levels that might contribute to\u00a0unaffordable short-term cost growth for the overall health care system. ICER\u2019s reports incorporate extensive input from all stakeholders and are the subject of public hearings through\u00a0three core programs: the California Technology Assessment Forum (CTAF), the Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC) and the New England Comparative Effectiveness Public Advisory Council (New England CEPAC). These independent panels review ICER\u2019s reports at public meetings to deliberate on the evidence and develop recommendations for how patients, clinicians, insurers, and policymakers can improve the quality and value of health care. For more information about ICER, please visit\u00a0ICER\u2019s website.<\/p>\n<p><a href=\"\/department-of-pharmacy\/department-info\/department-news\/\">Link to Department of Pharmacy archived news<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage UWSOP\u2019s expertise in economic modeling of pharmaceutical interventions to support ICER\u2019s growing&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[122,85],"class_list":["post-12761","post","type-post","status-publish","format-standard","hentry","category-pharmacy-news","tag-icer","tag-porpp"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy<\/title>\n<meta name=\"description\" content=\"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:published_time\" content=\"2016-01-28T18:00:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-26T20:15:18+00:00\" \/>\n<meta name=\"author\" content=\"Tim Wentzel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tim Wentzel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/\"},\"author\":{\"name\":\"Tim Wentzel\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\"},\"headline\":\"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications\",\"datePublished\":\"2016-01-28T18:00:16+00:00\",\"dateModified\":\"2023-07-26T20:15:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/\"},\"wordCount\":712,\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"keywords\":[\"ICER\",\"PORPP\"],\"articleSection\":[\"Pharmacy News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/\",\"name\":\"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"datePublished\":\"2016-01-28T18:00:16+00:00\",\"dateModified\":\"2023-07-26T20:15:18+00:00\",\"description\":\"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/uwsop-and-icer-form-collaboration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\",\"name\":\"Tim Wentzel\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy","description":"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/","og_locale":"en_US","og_type":"article","og_title":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy","og_description":"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_published_time":"2016-01-28T18:00:16+00:00","article_modified_time":"2023-07-26T20:15:18+00:00","author":"Tim Wentzel","twitter_card":"summary_large_image","twitter_creator":"@UW_Pharmacy","twitter_site":"@UW_Pharmacy","twitter_misc":{"Written by":"Tim Wentzel","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/#article","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/"},"author":{"name":"Tim Wentzel","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f"},"headline":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications","datePublished":"2016-01-28T18:00:16+00:00","dateModified":"2023-07-26T20:15:18+00:00","mainEntityOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/"},"wordCount":712,"publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"keywords":["ICER","PORPP"],"articleSection":["Pharmacy News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/","name":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"datePublished":"2016-01-28T18:00:16+00:00","dateModified":"2023-07-26T20:15:18+00:00","description":"The University of Washington School of Pharmacy (UWSOP) and the Institute for Clinical and Economic Review (ICER) have formed a partnership to leverage","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/uwsop-and-icer-form-collaboration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"UWSOP and ICER form collaboration to model the clinical and economic impact of new medications"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]},{"@type":"Person","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f","name":"Tim Wentzel"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/12761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=12761"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/12761\/revisions"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=12761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/categories?post=12761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/tags?post=12761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}